Trial Profile
Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Feb 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 05 Dec 2007 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 20 Nov 2007 Status changed from in progress to completed.
- 05 Nov 2007 Status changed from recruiting to in progress.